Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Efficacy of Methylene Blue Plus Ropivacaine for Post-Hemorrhoidectomy Pain. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of a methylene blue plus ropivacaine combination for reducing post-hemorrhoidectomy pain, sponsored by T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)
  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: The Affiliated Hospital of Putian University | Conditions: Mixed Hemorrhoids, Milligan-Morgan Hemorrhoidectomy | Phase 4 | Status: NOT_YET_RECRUITING